AZZOLINA, ANTONINA

AZZOLINA, ANTONINA  

Istituto per la Ricerca e l'Innovazione Biomedica -IRIB  

Mostra records
Risultati 1 - 20 di 79 (tempo di esecuzione: 0.066 secondi).
Titolo Data di pubblicazione Autore(i) File
New Insights into the Behavior of NHC-Gold Complexes in Cancer Cells 1-gen-2023 Augello, Giuseppa; Azzolina, Antonina; Rossi, Filomena; Prencipe, Filippo; Mangiatordi, GIUSEPPE FELICE; Saviano, Michele; Ronga, Luisa; Cervello, Melchiorre; Tesauro, Diego
Hepatocellular Carcinoma: A Difficult Cancer to Treat 1-gen-2021 Cusimano, Antonella; Soresi, Maurizio; Montalto, Giuseppe; Augello, Giuseppa; Emma, MARIA RITA; Azzolina, Antonina; Cervello, Melchiorre; Giannitrapani, Lydia
Potential uses of olive oil secoiridoids for the prevention and treatment of cancer: A narrative review of preclinical studies 1-gen-2021 Emma, Mr; Augello, G; Di Stefano, V; Azzolina, A; Giannitrapani, L; Montalto, G; Cervello, M; Cusimano, A
The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma 1-gen-2021 Augello, Giuseppa; Emma, MARIA RITA; Azzolina, Antonina; Puleio, Roberto; Condorelli, Lucia; Cusimano, Antonella; Giannitrapani, Lydia; A McCubrey, James; Lucio Iovanna, Juan; Cervello, Melchiorre
GSK-3 in liver diseases: Friend or foe? 1-gen-2020 Emma MR; Augello G; Cusimano A; Azzolina A; Montalto G; McCubrey JA; Cervello M;
Identification of an LPS-Induced Chemo-Attractive Peptide from Ciona robusta 1-gen-2020 Valeria Longo; Alessandra Longo; Annamaria Martorana; Antonino Lauria; Giuseppa Augello; Antonina Azzolina; Melchiorre Cervello; Paolo Colombo;
The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment 1-gen-2020 Augello G; Emma MR; Cusimano A; Azzolina A; Montalto G; McCubrey JA; Cervello M;
RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma 1-gen-2019 Akula, Sm; Abrams, Sl; Steelman, Ls; Emma, Mr; Augello, G; Cusimano, A; Azzolina, A; Montalto, G; Cervello, M; Mccubrey, Ja
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma 1-gen-2019 Augello, G; Emma, Mr; Cusimano, A; Azzolina, A; Mongiovi, S; Puleio, R; Cassata, G; Gulino, A; Belmonte, B; Gramignoli, R; Strom, Sc; Mccubrey, Ja; Montalto, G; Cervello, M
Cationic Solid Lipid Nanoparticles as Non Viral Vectors for the Inhibition of Hepatocellular Carcinoma Growth by RNA Interference 1-gen-2018 Chiara Botto; Giuseppa Augello; Erika Amore; Maria Rita Emma; Antonina Azzolina; Gennara Cavallaro; Melchiorre Cervello; Maria Luisa BondìChiara Botto; Giuseppa Augello; Erika Amore; Maria Rita Emma; Antonina Azzolina; Gennara Cavallaro; Melchiorre Cervello; Maria Luisa Bondì
Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells 1-gen-2018 Augello, Giuseppa; Modica, Martina; Azzolina, Antonina; Puleio, Roberto; Cassata, Giovanni; Emma, MARIA RITA; DI SANO, Caterina; Cusimano, Antonella; Montalto, Giuseppe; Cervello, Melchiorre
Biocompatible Lipid Nanoparticles as Carriers to Improve Curcumin Efficacy in Ovarian Cancer Treatment 1-gen-2017 Maria Luisa Bondì; Maria Rita Emma; Chiara Botto; Giuseppa Augello; Antonina Azzolina; Francesca Di Gaudio; Emanuela Fabiola Craparo; Gennara Cavallaro; Dimcho Bachvarov; Melchiorre Cervello
Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation 1-gen-2017 Cervello M.; Pitarresi G.; Volpe A.B.; Porsio B.; Balasus D.; Emma M.R.; Azzolina A.; Puleio R.; Loria G.R.; Puleo S.; Giammona G.
Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation 1-gen-2017 Cusimano A.; Balasus D.; Azzolina A.; Augello G.; Emma M.R.; Di Sano C.; Gramignoli R.; Strom S.C.; McCubrey J.A.; Montalto G.; Cervello M.
Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma 1-gen-2017 Cervello M.; Augello G.; Cusimano A.; Emma M.R.; Balasus D.; Azzolina A.; McCubrey J.A.; Montalto G.
In vitro and in vivo antitumor activity of the proteasome inhibitor MLN2238 in hepatocellular carcinoma cells 1-gen-2016 Augello, Giuseppa; Emma, MARIA RITA; Modica, Martina; DI SANO, Caterina; Puleio, Roberto; Azzolina, Antonina; Cusimano, Antonella; Montalto Melchiorre Cervello, Giuseppe
Emerging Use of Nanotechnology for the Treatment of Liver Diseases 1-gen-2015 Melchiorre Cervello; Lydia Giannitrapani; Maria Rita Emma; Giuseppa Augello; Antonella Cusimano; Daniele Balasus; Antonina Azzolina; Maurizio Soresi; Giuseppe Montalto
Nanoassemblies Based on Supramolecular Complexes of Nonionic Amphiphilic Cyclodextrin and Sorafenib as Effective Weapons to Kill Human HCC Cells 1-gen-2015 Bondi, Maria Luisa; Scala, Angela; Sortino, Giuseppe; Amore, Erika; Botto, Chiara; Azzolina, Antonina; Balasus, Daniele; Cervello, Melchiorre; Mazzaglia, Antonino
From targets to targeted therapies in Hepatocellular carcinoma 1-gen-2014 Cervello M.; Emma M.R.; Augello G.; Balasus D.; Azzolina A.; McCubrey J.A.; Cusimano A.
Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. 1-gen-2013 Cervello M; Bachvarov D; Lampiasi N; Cusimano A; Azzolina A; McCubrey JA; Montalto G.